APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclophosphamide Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cyclophosphamide Injection Industry Growth and Trends Forecast to 2032

29 December 2025105 pages

Choose your research edition.

Industry ResearchCyclophosphamide Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclophosphamide Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Cyclophosphamide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclophosphamide Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclophosphamide Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cyclophosphamide Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cyclophosphamide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cyclophosphamide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclophosphamide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclophosphamide Injection include Amneal Pharmaceuticals, Athenex, Aurobindo Pharma, Getwell Oncology, GLS Pharma, Ingenus, NorthStar Rx LLC, Zydus Cadila and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cyclophosphamide Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclophosphamide Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclophosphamide Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclophosphamide Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cyclophosphamide Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclophosphamide Injection Market by Company

Amneal Pharmaceuticals

Athenex

Aurobindo Pharma

Getwell Oncology

GLS Pharma

Ingenus

NorthStar Rx LLC

Zydus Cadila

Baxter

Jiangsu Hengrui Medicine

Pfizer

Novartis

Cyclophosphamide Injection Segment by Type

High-Dose

Low-Dose

Cyclophosphamide Injection Segment by Application

AL Amyloidosis

Cancer

Autoimmune Diseases

Others

Cyclophosphamide Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclophosphamide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclophosphamide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclophosphamide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclophosphamide Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cyclophosphamide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of High-Dose Table 2. Major Company of Low-Dose Table 3. Global Cyclophosphamide Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cyclophosphamide Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Cyclophosphamide Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cyclophosphamide Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cyclophosphamide Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Cyclophosphamide Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Cyclophosphamide Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Cyclophosphamide Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cyclophosphamide Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cyclophosphamide Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Cyclophosphamide Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Cyclophosphamide Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Cyclophosphamide Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cyclophosphamide Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Cyclophosphamide Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cyclophosphamide Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Cyclophosphamide Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cyclophosphamide Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Cyclophosphamide Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cyclophosphamide Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Cyclophosphamide Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Cyclophosphamide Injection Industry Trends Table 25. Cyclophosphamide Injection Industry Drivers Table 26. Cyclophosphamide Injection Industry Opportunities and Challenges Table 27. Cyclophosphamide Injection Industry Restraints Table 28. Global Cyclophosphamide Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cyclophosphamide Injection Revenue Market Share by Company (2021-2026) Table 30. Global Cyclophosphamide Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Cyclophosphamide Injection Sales Share by Company (2021-2026) Table 32. Global Cyclophosphamide Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Cyclophosphamide Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cyclophosphamide Injection Major Company Production Sites and Headquarters Table 35. Global Cyclophosphamide Injection Company, Product Type & Application Table 36. Global Cyclophosphamide Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cyclophosphamide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cyclophosphamide Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cyclophosphamide Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Cyclophosphamide Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cyclophosphamide Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cyclophosphamide Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Cyclophosphamide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cyclophosphamide Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Cyclophosphamide Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cyclophosphamide Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cyclophosphamide Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Cyclophosphamide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cyclophosphamide Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cyclophosphamide Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Cyclophosphamide Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cyclophosphamide Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cyclophosphamide Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Cyclophosphamide Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Cyclophosphamide Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Cyclophosphamide Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cyclophosphamide Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cyclophosphamide Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Cyclophosphamide Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Cyclophosphamide Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Cyclophosphamide Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cyclophosphamide Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Cyclophosphamide Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cyclophosphamide Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Cyclophosphamide Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cyclophosphamide Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Cyclophosphamide Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cyclophosphamide Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Cyclophosphamide Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Amneal Pharmaceuticals Company Information Table 72. Amneal Pharmaceuticals Business Overview Table 73. Amneal Pharmaceuticals Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Amneal Pharmaceuticals Cyclophosphamide Injection Product Portfolio Table 75. Amneal Pharmaceuticals Recent Development Table 76. Athenex Company Information Table 77. Athenex Business Overview Table 78. Athenex Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Athenex Cyclophosphamide Injection Product Portfolio Table 80. Athenex Recent Development Table 81. Aurobindo Pharma Company Information Table 82. Aurobindo Pharma Business Overview Table 83. Aurobindo Pharma Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Aurobindo Pharma Cyclophosphamide Injection Product Portfolio Table 85. Aurobindo Pharma Recent Development Table 86. Getwell Oncology Company Information Table 87. Getwell Oncology Business Overview Table 88. Getwell Oncology Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Getwell Oncology Cyclophosphamide Injection Product Portfolio Table 90. Getwell Oncology Recent Development Table 91. GLS Pharma Company Information Table 92. GLS Pharma Business Overview Table 93. GLS Pharma Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GLS Pharma Cyclophosphamide Injection Product Portfolio Table 95. GLS Pharma Recent Development Table 96. Ingenus Company Information Table 97. Ingenus Business Overview Table 98. Ingenus Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Ingenus Cyclophosphamide Injection Product Portfolio Table 100. Ingenus Recent Development Table 101. NorthStar Rx LLC Company Information Table 102. NorthStar Rx LLC Business Overview Table 103. NorthStar Rx LLC Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. NorthStar Rx LLC Cyclophosphamide Injection Product Portfolio Table 105. NorthStar Rx LLC Recent Development Table 106. Zydus Cadila Company Information Table 107. Zydus Cadila Business Overview Table 108. Zydus Cadila Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zydus Cadila Cyclophosphamide Injection Product Portfolio Table 110. Zydus Cadila Recent Development Table 111. Baxter Company Information Table 112. Baxter Business Overview Table 113. Baxter Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Baxter Cyclophosphamide Injection Product Portfolio Table 115. Baxter Recent Development Table 116. Jiangsu Hengrui Medicine Company Information Table 117. Jiangsu Hengrui Medicine Business Overview Table 118. Jiangsu Hengrui Medicine Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Jiangsu Hengrui Medicine Cyclophosphamide Injection Product Portfolio Table 120. Jiangsu Hengrui Medicine Recent Development Table 121. Pfizer Company Information Table 122. Pfizer Business Overview Table 123. Pfizer Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Pfizer Cyclophosphamide Injection Product Portfolio Table 125. Pfizer Recent Development Table 126. Novartis Company Information Table 127. Novartis Business Overview Table 128. Novartis Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Novartis Cyclophosphamide Injection Product Portfolio Table 130. Novartis Recent Development Table 131. North America Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Cyclophosphamide Injection Sales by Country (2021-2026) & (K Units) Table 133. North America Cyclophosphamide Injection Sales Market Share by Country (2021-2026) Table 134. North America Cyclophosphamide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Cyclophosphamide Injection Sales Market Share Forecast by Country (2027-2032) Table 136. North America Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Cyclophosphamide Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Cyclophosphamide Injection Market Share by Country (2021-2026) Table 139. North America Cyclophosphamide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Cyclophosphamide Injection Market Share Forecast by Country (2027-2032) Table 141. Europe Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Cyclophosphamide Injection Sales by Country (2021-2026) & (K Units) Table 143. Europe Cyclophosphamide Injection Sales Market Share by Country (2021-2026) Table 144. Europe Cyclophosphamide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Cyclophosphamide Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Cyclophosphamide Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Cyclophosphamide Injection Market Share by Country (2021-2026) Table 149. Europe Cyclophosphamide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Cyclophosphamide Injection Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Cyclophosphamide Injection Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Cyclophosphamide Injection Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Cyclophosphamide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Cyclophosphamide Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Cyclophosphamide Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Cyclophosphamide Injection Market Share by Country (2021-2026) Table 159. Asia-Pacific Cyclophosphamide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Cyclophosphamide Injection Market Share Forecast by Country (2027-2032) Table 161. Latin America Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Cyclophosphamide Injection Sales by Country (2021-2026) & (K Units) Table 163. Latin America Cyclophosphamide Injection Sales Market Share by Country (2021-2026) Table 164. Latin America Cyclophosphamide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Cyclophosphamide Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Cyclophosphamide Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Cyclophosphamide Injection Market Share by Country (2021-2026) Table 169. Latin America Cyclophosphamide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Cyclophosphamide Injection Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Cyclophosphamide Injection Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Cyclophosphamide Injection Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Cyclophosphamide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Cyclophosphamide Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Cyclophosphamide Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Cyclophosphamide Injection Market Share by Country (2021-2026) Table 179. Middle East and Africa Cyclophosphamide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Cyclophosphamide Injection Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Cyclophosphamide Injection Distributors List Table 184. Cyclophosphamide Injection Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Cyclophosphamide Injection Image Figure 2. Global Cyclophosphamide Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclophosphamide Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclophosphamide Injection Sales (2021-2032) & (K Units) Figure 5. High-Dose Image Figure 6. Global High-Dose Sales YoY Growth (2021-2032) & (K Units) Figure 7. Low-Dose Image Figure 8. Global Low-Dose Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Cyclophosphamide Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cyclophosphamide Injection Market Share by Type 2025 VS 2032 Figure 11. North America Cyclophosphamide Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Cyclophosphamide Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Cyclophosphamide Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cyclophosphamide Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cyclophosphamide Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cyclophosphamide Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cyclophosphamide Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cyclophosphamide Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cyclophosphamide Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cyclophosphamide Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cyclophosphamide Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. AL Amyloidosis Image Figure 24. Global AL Amyloidosis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Cancer Image Figure 26. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Autoimmune Diseases Image Figure 28. Global Autoimmune Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Cyclophosphamide Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cyclophosphamide Injection Market Share by Application 2025 VS 2032 Figure 33. North America Cyclophosphamide Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Cyclophosphamide Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Cyclophosphamide Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cyclophosphamide Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cyclophosphamide Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cyclophosphamide Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cyclophosphamide Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cyclophosphamide Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cyclophosphamide Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cyclophosphamide Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Cyclophosphamide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Cyclophosphamide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cyclophosphamide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cyclophosphamide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cyclophosphamide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Cyclophosphamide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cyclophosphamide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cyclophosphamide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cyclophosphamide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Cyclophosphamide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cyclophosphamide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cyclophosphamide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cyclophosphamide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Cyclophosphamide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cyclophosphamide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cyclophosphamide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cyclophosphamide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Cyclophosphamide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cyclophosphamide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cyclophosphamide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cyclophosphamide Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cyclophosphamide Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • High-Dose
  • Low-Dose
Applications
  • AL Amyloidosis
  • Cancer
  • Autoimmune Diseases
  • Others
Companies covered
  • Amneal Pharmaceuticals
  • Athenex
  • Aurobindo Pharma
  • Getwell Oncology
  • GLS Pharma
  • Ingenus
  • NorthStar Rx LLC
  • Zydus Cadila
  • Baxter
  • Jiangsu Hengrui Medicine
  • Pfizer
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclophosphamide Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclophosphamide Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cyclophosphamide Injection Market by Type
  6. 1.3.1 High-Dose
  7. 1.3.2 Low-Dose
  8. 1.4 Global Cyclophosphamide Injection Market Size by Type
  9. 1.4.1 Global Cyclophosphamide Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cyclophosphamide Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cyclophosphamide Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cyclophosphamide Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cyclophosphamide Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cyclophosphamide Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cyclophosphamide Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cyclophosphamide Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cyclophosphamide Injection Industry Trends
  2. 2.2 Cyclophosphamide Injection Industry Drivers
  3. 2.3 Cyclophosphamide Injection Industry Opportunities and Challenges
  4. 2.4 Cyclophosphamide Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cyclophosphamide Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Cyclophosphamide Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Cyclophosphamide Injection Price (2021-2026)
  4. 3.4 Global Cyclophosphamide Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclophosphamide Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Cyclophosphamide Injection Company, Product Type & Application
  7. 3.7 Global Cyclophosphamide Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclophosphamide Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclophosphamide Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclophosphamide Injection Tier 1, Tier 2, and Tier 3
4 Cyclophosphamide Injection Regional Status and Outlook
  1. 4.1 Global Cyclophosphamide Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cyclophosphamide Injection Historic Market Size by Region
  3. 4.2.1 Global Cyclophosphamide Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cyclophosphamide Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cyclophosphamide Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cyclophosphamide Injection Forecasted Market Size by Region
  7. 4.3.1 Global Cyclophosphamide Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cyclophosphamide Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cyclophosphamide Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyclophosphamide Injection by Application
  1. 5.1 Cyclophosphamide Injection Market by Application
  2. 5.1.1 AL Amyloidosis
  3. 5.1.2 Cancer
  4. 5.1.3 Autoimmune Diseases
  5. 5.1.4 Others
  6. 5.2 Global Cyclophosphamide Injection Market Size by Application
  7. 5.2.1 Global Cyclophosphamide Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cyclophosphamide Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cyclophosphamide Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cyclophosphamide Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cyclophosphamide Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cyclophosphamide Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cyclophosphamide Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cyclophosphamide Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amneal Pharmaceuticals
  2. 6.1.1 Amneal Pharmaceuticals Company Information
  3. 6.1.2 Amneal Pharmaceuticals Business Overview
  4. 6.1.3 Amneal Pharmaceuticals Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amneal Pharmaceuticals Cyclophosphamide Injection Product Portfolio
  6. 6.1.5 Amneal Pharmaceuticals Recent Developments
  7. 6.2 Athenex
  8. 6.2.1 Athenex Company Information
  9. 6.2.2 Athenex Business Overview
  10. 6.2.3 Athenex Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Athenex Cyclophosphamide Injection Product Portfolio
  12. 6.2.5 Athenex Recent Developments
  13. 6.3 Aurobindo Pharma
  14. 6.3.1 Aurobindo Pharma Company Information
  15. 6.3.2 Aurobindo Pharma Business Overview
  16. 6.3.3 Aurobindo Pharma Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aurobindo Pharma Cyclophosphamide Injection Product Portfolio
  18. 6.3.5 Aurobindo Pharma Recent Developments
  19. 6.4 Getwell Oncology
  20. 6.4.1 Getwell Oncology Company Information
  21. 6.4.2 Getwell Oncology Business Overview
  22. 6.4.3 Getwell Oncology Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Getwell Oncology Cyclophosphamide Injection Product Portfolio
  24. 6.4.5 Getwell Oncology Recent Developments
  25. 6.5 GLS Pharma
  26. 6.5.1 GLS Pharma Company Information
  27. 6.5.2 GLS Pharma Business Overview
  28. 6.5.3 GLS Pharma Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GLS Pharma Cyclophosphamide Injection Product Portfolio
  30. 6.5.5 GLS Pharma Recent Developments
  31. 6.6 Ingenus
  32. 6.6.1 Ingenus Company Information
  33. 6.6.2 Ingenus Business Overview
  34. 6.6.3 Ingenus Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ingenus Cyclophosphamide Injection Product Portfolio
  36. 6.6.5 Ingenus Recent Developments
  37. 6.7 NorthStar Rx LLC
  38. 6.7.1 NorthStar Rx LLC Company Information
  39. 6.7.2 NorthStar Rx LLC Business Overview
  40. 6.7.3 NorthStar Rx LLC Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NorthStar Rx LLC Cyclophosphamide Injection Product Portfolio
  42. 6.7.5 NorthStar Rx LLC Recent Developments
  43. 6.8 Zydus Cadila
  44. 6.8.1 Zydus Cadila Company Information
  45. 6.8.2 Zydus Cadila Business Overview
  46. 6.8.3 Zydus Cadila Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Cadila Cyclophosphamide Injection Product Portfolio
  48. 6.8.5 Zydus Cadila Recent Developments
  49. 6.9 Baxter
  50. 6.9.1 Baxter Company Information
  51. 6.9.2 Baxter Business Overview
  52. 6.9.3 Baxter Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Baxter Cyclophosphamide Injection Product Portfolio
  54. 6.9.5 Baxter Recent Developments
  55. 6.10 Jiangsu Hengrui Medicine
  56. 6.10.1 Jiangsu Hengrui Medicine Company Information
  57. 6.10.2 Jiangsu Hengrui Medicine Business Overview
  58. 6.10.3 Jiangsu Hengrui Medicine Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Hengrui Medicine Cyclophosphamide Injection Product Portfolio
  60. 6.10.5 Jiangsu Hengrui Medicine Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Cyclophosphamide Injection Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Novartis
  68. 6.12.1 Novartis Company Information
  69. 6.12.2 Novartis Business Overview
  70. 6.12.3 Novartis Cyclophosphamide Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Novartis Cyclophosphamide Injection Product Portfolio
  72. 6.12.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Cyclophosphamide Injection Sales by Country
  2. 7.1.1 North America Cyclophosphamide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cyclophosphamide Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Cyclophosphamide Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cyclophosphamide Injection Market Size by Country
  6. 7.2.1 North America Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cyclophosphamide Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Cyclophosphamide Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cyclophosphamide Injection Sales by Country
  2. 8.1.1 Europe Cyclophosphamide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cyclophosphamide Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Cyclophosphamide Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cyclophosphamide Injection Market Size by Country
  6. 8.2.1 Europe Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cyclophosphamide Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cyclophosphamide Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cyclophosphamide Injection Sales by Country
  2. 9.1.1 Asia-Pacific Cyclophosphamide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cyclophosphamide Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cyclophosphamide Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cyclophosphamide Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cyclophosphamide Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cyclophosphamide Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cyclophosphamide Injection Sales by Country
  2. 10.1.1 South America Cyclophosphamide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cyclophosphamide Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Cyclophosphamide Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cyclophosphamide Injection Market Size by Country
  6. 10.2.1 South America Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cyclophosphamide Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Cyclophosphamide Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cyclophosphamide Injection Sales by Country
  2. 11.1.1 Middle East and Africa Cyclophosphamide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cyclophosphamide Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cyclophosphamide Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cyclophosphamide Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Cyclophosphamide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cyclophosphamide Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cyclophosphamide Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cyclophosphamide Injection Value Chain Analysis
  2. 12.1.1 Cyclophosphamide Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cyclophosphamide Injection Production Mode & Process
  7. 12.2 Cyclophosphamide Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cyclophosphamide Injection Distributors
  10. 12.2.3 Cyclophosphamide Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst